GENTEX CORP
10-Q, 1996-04-30
MOTOR VEHICLE PARTS & ACCESSORIES
Previous: SMITH BARNEY SHEARSON INVESTMENT FUNDS INC, 485B24E, 1996-04-30
Next: FRANKLIN LIFE MONEY MARKET VARIABLE ANNUITY FUND C, 485BPOS, 1996-04-30



<PAGE>   1
                       SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D. C.  20549

                                   FORM 10-Q


(MARK ONE)
[ X ]  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 1996,  OR
[   ]  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
       EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM _________ TO
       ___________



COMMISSION FILE NO. 0-10235

                               GENTEX CORPORATION
             (Exact name of registrant as specified in its charter)


            MICHIGAN                                   38-2030505
 (State or other jurisdiction of           (I.R.S. Employer Identification No.)
 incorporation or organization)

   600 N. CENTENNIAL, ZEELAND, MICHIGAN                    49464
 (Address of principal executive offices)               (Zip Code)


                                 (616) 772-1800
              (Registrant's telephone number, including area code)


- --------------------------------------------------------------------------------
       (Former name, former address and former fiscal year, if changed
                              since last report)

Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of
1934 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports), and (2) has been subject to such
filing requirements for the past 90 days.

            Yes__x__            No_____

APPLICABLE ONLY TO ISSUERS INVOLVED IN BANKRUPTCY PROCEEDINGS DURING THE
PRECEDING FIVE YEARS:

Indicate by check mark whether the registrant has filed all documents and
reports required to be filed by Sections 12, 13 or 15(d) of the Securities
Exchange Act of 1934 subsequent to the distribution of securities under a plan
confirmed by a court.
            Yes_____            No_____

APPLICABLE ONLY TO CORPORATE USERS:

Indicate the number of shares outstanding of each of the issuer's classes of
common stock, as of the latest practicable date.


                                              Shares Outstanding
               Class                          at April 16, 1996
               -----                          ------------------
    Common Stock, $0.06 Par Value                17,082,982




                        Exhibit Index located at page  9




                                 Page 1 of 10



<PAGE>   2

PART I.     FINANCIAL INFORMATION

ITEM 1.     CONSOLIDATED FINANCIAL STATEMENTS

                     GENTEX CORPORATION AND SUBSIDIARIES

                     CONDENSED CONSOLIDATED BALANCE SHEETS

                    At March 31, 1996 and December 31, 1995



<TABLE>
<CAPTION>
                                           ASSETS

                                                            March 31, 1996         December 31, 1995
                                                            --------------         -----------------
<S>                                                            <C>                      <C>
CURRENT ASSETS
   Cash and cash equivalents                                    $13,676,787              $14,115,041
   Short term investments                                        22,894,463               20,162,189
   Accounts receivable, net                                      16,432,759               14,706,156
   Inventories                                                    6,350,404                5,735,519
   Prepaid expenses and other                                       621,891                1,342,640
                                                              -------------            -------------

      Total current assets                                       59,976,304               56,061,545

PLANT AND EQUIPMENT - NET                                        22,363,104               18,942,115

OTHER ASSETS
   Long-term investments                                         35,076,554               32,146,422
   Patents and other assets, net                                  2,161,078                2,093,439
                                                              -------------            -------------

      Total other assets                                         37,237,632               34,239,861
                                                              -------------            -------------

Total assets                                                   $119,577,040             $109,243,521
                                                              =============            =============


                    LIABILITIES AND SHAREHOLDERS' INVESTMENT

<CAPTION>

<S>                                                            <C>                      <C>
CURRENT LIABILITIES
   Accounts payable                                              $7,216,185               $5,422,658
   Accrued liabilities                                           10,717,496                8,627,409
                                                              -------------            -------------

      Total current liabilities                                  17,933,681               14,050,067

DEFERRED INCOME TAXES                                             1,097,140                  521,674

SHAREHOLDERS' INVESTMENT
   Common stock                                                   1,024,979                1,013,752
   Additional paid-in capital                                    39,456,190               37,128,320
   Other shareholder's equity                                    60,065,050               56,529,708
                                                              -------------            -------------

      Total shareholders' investment                            100,546,219               94,671,780
                                                              -------------            -------------

Total liabilities and
   shareholders' investment                                    $119,577,040             $109,243,521
                                                              =============            =============

</TABLE>



     See accompanying notes to condensed consolidated financial statements.


                                     - 2 -





<PAGE>   3

                     GENTEX CORPORATION AND SUBSIDIARIES

                 CONDENSED CONSOLIDATED STATEMENTS OF INCOME

             For the Three Months Ended March 31, 1996 and 1995



<TABLE>
<CAPTION>
                                                 1996            1995
                                              -----------     -----------
<S>                                           <C>             <C>
NET SALES                                     $35,908,083     $26,042,968

COST OF GOODS SOLD                             22,377,952      15,426,405
                                              -----------     -----------


      Gross profit                             13,530,131      10,616,563


OPERATING EXPENSES:
   Research and development                     1,727,234       1,388,550
   Selling, general
      & administrative                          3,642,004       3,068,884
   Patent settlement                            4,000,000               0
                                              -----------     -----------

      Total operating expenses                  9,369,238       4,457,434
                                              -----------     -----------

      Income from operations                    4,160,893       6,159,129


OTHER INCOME
   Interest and dividend income                   815,275         627,217
   Other, net                                      17,481          61,836
                                              -----------     -----------

      Total other income                          832,756         689,053
                                              -----------     -----------

      Income before provision
         for federal income taxes               4,993,649       6,848,182

PROVISION FOR FEDERAL INCOME TAXES              1,648,000       2,261,000
                                              -----------     -----------


NET INCOME                                     $3,345,649      $4,587,182
                                              ===========     ===========

EARNINGS PER SHARE                                  $0.19           $0.27


WEIGHTED DAILY AVERAGE OF
COMMON STOCK OUTSTANDING                       17,380,981      17,057,610
</TABLE>



   See accompanying notes to condensed consolidated financial statements.



                                     - 3 -
                                      



<PAGE>   4

                     GENTEX CORPORATION AND SUBSIDIARIES

               CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

             For the Three Months Ended March 31, 1996 and 1995



<TABLE>
<CAPTION>
                                                               1996              1995
                                                           ------------      ------------
        <S>                                                 <C>               <C>
        CASH FLOWS FROM OPERATING ACTIVITIES:
           Net income                                        $3,345,649        $4,587,182
           Adjustments to reconcile net income to net
              cash provided by operating activities-
                 Depreciation and amortization                  989,598           764,609
                 Gain on disposal of equipment                        0            (5,000)
                 Deferred income taxes                        1,362,768            78,160
                 Amortization of deferred compensation          115,510            74,477
                 Change in assets and liabilities:
                    Accounts receivable, net                 (1,726,603)           91,069
                    Inventories                                (614,885)          171,487
                    Prepaid expenses and other                  (66,553)          148,656
                    Accounts payable                          1,793,527            25,577
                    Accrued liabilities                       2,090,087         2,146,234
                                                           ------------      ------------
                Net cash provided by
                   operating activities                       7,289,098         8,082,451
                                                           ------------      ------------

        CASH FLOWS FROM INVESTING ACTIVITIES:
           Increase in short-term investments                (2,732,274)       (4,187,898)
           Plant and equipment additions                     (4,363,901)       (1,012,232)
           Proceeds from sale of plant and equipment                  0             5,000
           Decrease (Increase) in long-term investments      (2,954,245)        1,477,025
           Increase in other assets                             (99,591)          (23,669)
                                                           ------------      ------------
                Net cash used for
                   investing activities                     (10,150,011)       (3,741,774)
                                                           ------------      ------------

        CASH FLOWS FROM FINANCING ACTIVITIES:
           Issuance of common stock and tax benefit of
             stock plan transactions                          2,422,659         1,445,095
                                                           ------------      ------------
                Net cash provided by
                   financing activities                       2,422,659         1,445,095
                                                           ------------      ------------


        NET INCREASE (DECREASE) IN CASH AND
           CASH EQUIVALENTS                                    (438,254)        5,785,772

        CASH AND CASH EQUIVALENTS,
           beginning of period                               14,115,041        11,183,991
                                                           ------------      ------------

        CASH AND CASH EQUIVALENTS,
           end of period                                    $13,676,787       $16,969,763
                                                           ============      ============
</TABLE>


    See accompanying notes to condensed consolidated financial statements

                                     - 4 -
<PAGE>   5
                     GENTEX  CORPORATION  AND  SUBSIDIARIES

              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS


(1)  The condensed consolidated financial statements included herein have been
     prepared by the Registrant, without audit, pursuant to the rules and
     regulations of the Securities and Exchange Commission.  Certain
     information and footnote disclosures normally included in financial
     statements prepared in accordance with generally accepted accounting
     principles have been condensed or omitted pursuant to such rules and
     regulations, although the Registrant believes that the disclosures are
     adequate to make the information presented not misleading.  It is
     suggested that these condensed consolidated financial statements be read
     in conjunction with the financial statements and notes thereto included in
     the Registrant's 1995 annual report on Form 10-K.

(2)  In the opinion of management, the accompanying unaudited condensed
     consolidated financial statements contain all adjustments, consisting of
     only a normal and recurring nature, necessary to present fairly the
     financial position of the Registrant as of March 31, 1996, and December
     31, 1995, and the results of operations and cash flows for the interim
     periods presented.

(3)  Inventories consisted of the following at the respective quarter end:


<TABLE>
<CAPTION>
                                March 31, 1996  December 31, 1995
                                --------------  -----------------
               <S>                <C>                 <C>
               Raw materials        $4,111,638         $3,294,254
               Work-in-process         358,206            358,206
               Finished goods        1,880,560          2,083,059
                                    ----------         ----------
                                    $6,350,404         $5,735,519
                                    ==========         ==========
</TABLE>


(4)  The Company has been involved in patent litigation with Donnelly
     Corporation since 1990 concerning a number of patents relating to
     electrochromic mirrors owned by the Company and Donnelly.

     During the quarter, the Company reached a settlement agreement with 
     Donnelly to resolve the patent litigation pending between the two 
     companies.  Under the agreement:

         The companies have cross-licensed certain patents (for the life of the
         patents) that each company may practice within its own "core"
         electrochromic technology area.

         The Company will pay Donnelly $6 million (plus a $200,000 contingent
         payment if Donnelly prevails in its lighted mirror patent appeal) as
         full and complete satisfaction of all of Donnelly's patent
         infringement claims.

         The companies agreed not to pursue litigation against each other on
         certain other patents for a period of four years.

     The Company recorded a one-time charge of $4,000,000 ($6,000,000 payment,
     net of accrued reserves) in connection with the settlement of its patent
     litigation with Donnelly.





                                    - 5 -


<PAGE>   6
                              GENTEX  CORPORATION

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF RESULTS OF OPERATIONS AND  
        FINANCIAL CONDITION

        RESULTS OF OPERATIONS:

        FIRST  QUARTER  1996  VERSUS  FIRST QUARTER  1995

        Net Sales.  Net sales for the first quarter of 1996 increased by
        approximately $9,865,000, or 38%, when compared with the first quarter
        last year.  Net sales of the Company's automotive mirrors increased by
        43% as automatic mirror unit shipments increased from approximately
        518,000 in the first quarter of 1995 to 720,000 in the current quarter.
        This increase primarily reflected increased penetration on domestic
        and foreign 1996 model year vehicles for interior and exterior
        electrochromic Night Vision Safety(TM) (NVS(R)) Mirrors.  Net sales of
        the Company's fire protection products increased 11%, as shipments to
        other customers offset reduced shipments of its strobe warning light to
        a major customer that has developed its own strobe product.

        Cost of Goods Sold.  As a percentage of net sales, cost of goods sold
        increased from 59% in the first quarter of 1995 to 62% for the
        comparable period in 1996.  This increased percentage primarily
        reflects automotive customer price reductions for the 1996 model year,
        as well as changes in the Company's product mix of automotive mirror
        shipments.

        Operating Expenses.  Research and development expenses increased
        approximately $339,000, but remained at 5% of net sales, when compared
        with the same quarter last year, primarily reflecting additional
        staffing and contractual services.  Selling, general and administrative
        expenses increased approximately $573,000, but decreased from 12% to
        10% of net sales, when compared with the first quarter of 1995.  This
        increased expense primarily reflected higher patent litigation legal
        expense accruals of $1,200,000, compared to $900,000 last year.  During
        the first quarter of 1996, the Company recorded a one-time charge of
        $4,000,000 ($6,000,000 payment, net of accrued reserves) in connection
        with the settlement of its patent litigation with Donnelly Corporation.

        Other Income - Net.   Investment income increased by approximately
        $188,000 when compared with the first quarter of 1995, primarily due to
        the higher investable fund balances and higher interest rates.


        FINANCIAL CONDITION:

        Management considers the Company's working capital and long-term
        investments totaling approximately $77,119,000 at March 31, 1996,
        together with internally generated cash flow and an unsecured
        $5,000,000 line of credit from a bank, to be sufficient to cover
        anticipated cash needs for the foreseeable future, including the
        payment of $6,000,000 in April 1996 to settle all outstanding patent
        litigation with Donnelly Corporation.

        TRENDS AND DEVELOPMENTS:

        The Company currently supplies NVS(R) Mirrors to BMW, Chrysler
        Corporation, Ford Motor Company and General Motors Corporation under
        long-term contracts.  The General Motors contract is through the 1998
        model year, and the contracts with BMW are for the four-year period
        ending March 31, 1999.  The term of the Ford contract is through
        December 1999, and the Chrysler contract runs through the 1999 Model
        Year.

        The Company has agreed to price reductions over the life of its
        long-term contracts and continues to experience pricing pressures from
        its automotive customers, which have affected, and which will continue
        to affect its margins to the extent that the Company is unable to
        offset the price reductions with productivity improvements, engineering
        cost reductions and increases in unit sales volume.  In addition, the
        Company continues to experience some pressure for raw material cost
        increases.


                                    - 6 -


<PAGE>   7
PART II.     OTHER INFORMATION
             

  Item 1.    Legal Proceedings

             During the quarter, the Company reached a settlement agreement 
             with Donnelly Corporation to resolve all patent litigation 
             pending between the two companies. See footnote (4) to the
             Condensed Consolidated Financial Statements on Page 5 of this 
             report.


  Item 6.    Exhibits and Reports on Form 8-K

  (a)        See Exhibit Index on Page 9.

  (b)        No reports on Form 8-K were filed during the three months ended
             March 31, 1996.








                                      - 7 -


<PAGE>   8
                                 SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.





                                 GENTEX CORPORATION





 Date  04/30/96                    /s/ Fred T. Bauer
      -----------                -----------------------------------
                                 Fred T. Bauer
                                 Chairman and Chief
                                 Executive Officer




 Date  04/30/96                    /s/ Enoch C. Jen
      -----------                -----------------------------------
                                 Enoch C. Jen
                                 Vice President-Finance,
                                 Principal Financial and
                                 Accounting Officer








                                    - 8 -

<PAGE>   9
                                 EXHIBIT INDEX


<TABLE>
<CAPTION>
EXHIBIT NO.                       DESCRIPTION                                        PAGE
- -----------                       -----------                                        ----
<S>        <C>                                                                       <C>
3(a)(1)    Registrant's Articles of Incorporation were filed in 1981 as
           Exhibit 2(a) to a Registration Statement on Form S-18
           (Registration No. 2-74226C), an Amendment to those Articles was
           filed as Exhibit 3 to Registrant's Report on Form 10-Q in August
           of 1985, an additional Amendment to those Articles was filed as
           Exhibit 3(a)(i) to Registrant's Report on Form 10-Q in August of
           1987, and an additional Amendment to those Articles was filed as
           Exhibit 3(a)(2) to Registrant's Report on Form 10-K dated March
           10, 1992, all of which are hereby incorporated herein by
           reference.
        
3(a)(2)    Amendment to Articles of Incorporation, adopted on May 12,
           1994, was filed as Exhibit 3(a)(2) to Registrant's Report on
           Form 10-Q dated April 28, 1995, and the same is hereby
           incorporated herein by reference.

3(b)       Registrant's Bylaws as amended and restated August 18, 1995 were
           filed as Exhibit 3(b) to Registrant's Report on Form 10-Q dated
           November 1, 1995, and the same is incororated herein by
           reference.

4(a)       A specimen form of certificate for the Registrant's common
           stock, par value $.06 per share, was filed as part of a
           Registration Statement on Form S-18 (Registration No. 2-74226C)
           as Exhibit 3(a), as amended by Amendment No. 3 to such
           Registration Statement, and the same is hereby incorporated
           herein by reference.
    
4(b)       Shareholder Protection Rights Agreement, dated as of August 26,
           1991, including as Exhibit A the form of Certificate of Adoption
           of Resolution Establishing Series of Shares of Junior
           Participating Preferred Stock of the Company, and as Exhibit B
           the form of Rights Certificate and of Election to Exercise, was
           filed as Exhibit 4(b) to Registrant's report on Form 8-K on
           August 20, 1991, and the same is hereby incorporated herein by
           reference.

4(b)(1)    First Amendment to Shareholder Protection Rights Agreement, effective
           April 1, 1994, was filed as Exhibit 4(b)(1) to Registrant's report on
           Form 10-Q on April 29, 1994, and the same is hereby incorporated
           herein by reference.

10(a)(1)   A Lease dated August 15, 1981, was filed as part of a
           Registration Statement (Registration Number 2-74226C) as Exhibit
           9(a)(1), and the same is hereby incorporated herein by reference.

10(a)(2)   A First Amendment to Lease dated June 28, 1985, was filed as
           Exhibit 10(m) to Registrant's Report on Form 10-K dated March 18,
           1986, and the same is hereby incorporated herein by reference.

*10(b)(1)  Gentex Corporation Qualified Stock Option Plan (as amended and
           restated, effective May 11, 1995), was filed as Exhibit 10(b)(1) to
           Registrant's Report on Form 10-Q dated August 1, 1995, and the same
           is hereby incorporated herein by reference. 

*10(b)(2)  Gentex Corporation 1987 Incentive Stock Option Plan (as amended through 
           May 24, 1989), was filed as Exhibit 10(g)(3) to Registrant's Report
           on Form 10-K dated March 1, 1990, and the same is hereby incorporated 
           herein by reference.


</TABLE>


                                      - 9 -

<PAGE>   10


<TABLE>
<CAPTION>
EXHIBIT NO.                       DESCRIPTION                                        PAGE
- -----------                       -----------                                        ----
<S>        <C>                                                                       <C>

*10(b)(3)  Gentex Corporation Restricted Stock Plan was filed as Exhibit 10(b)(3) 
           to Registrant's Report on Form 10-K dated March 10, 1992, and the same 
           is hereby incorporated herein by reference.

*10(b)(4)  Gentex Corporation Non-Employee Director Stock Option Plan as amended 
           through March 5, 1993, was filed as Exhibit 10(b)(4) to Registrant's 
           Report on Form 10-K dated March 5, 1993, and the same is incorporated 
           herein in reference.

10(e)      The form of Indemnity Agreement between Registrant and each of the 
           Registrant's directors was filed as a part of a Registration Statement 
           on Form S-2 (Registration No. 33-30353) as Exhibit 10(k) and the same
           is hereby incorporated herein by reference.

27         Financial Data Schedule




                     -------------------------------------------------





</TABLE>




*    Indicates a compensatory plan or arrangement.





                                    - 10 -



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-END>                               MAR-31-1996
<CASH>                                      13,676,787
<SECURITIES>                                22,894,463
<RECEIVABLES>                               16,622,293
<ALLOWANCES>                                 (189,534)
<INVENTORY>                                  6,350,404
<CURRENT-ASSETS>                            59,976,304
<PP&E>                                      35,535,574
<DEPRECIATION>                            (13,172,470)
<TOTAL-ASSETS>                             119,577,040
<CURRENT-LIABILITIES>                       17,933,681
<BONDS>                                              0
                                0
                                          0
<COMMON>                                     1,024,979
<OTHER-SE>                                  99,521,240
<TOTAL-LIABILITY-AND-EQUITY>               119,577,040
<SALES>                                     35,908,083
<TOTAL-REVENUES>                            35,908,083
<CGS>                                       22,377,952
<TOTAL-COSTS>                               31,747,190
<OTHER-EXPENSES>                             (832,756)
<LOSS-PROVISION>                                15,000
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                              4,993,649
<INCOME-TAX>                                 1,648,000
<INCOME-CONTINUING>                          3,345,649
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                 3,345,649
<EPS-PRIMARY>                                     0.19
<EPS-DILUTED>                                     0.19
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission